Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019
| Application Note
Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...
Roquette Pharma Solutions | 14-Jun-2019
| Case Study
Therapeutic proteins are inherently unstable and sensitive to temperature change, shearing, shaking, solvents, ionic strength, purity, protein concentration,...
How can you bring your innovation strategy to life? Step into an M Lab™ Collaboration Center and bring life-saving therapies to market faster:
• Explore...
CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...
Marken: Global Life Science Supply Chain Solutions | Recorded the 10-Oct-2018 | Webinar
Study protocols are increasingly complex with the need for extensive data collection despite complicated drug regimes. Patients may be deterred from taking...
Eppendorf for Bioprocess – Solutions that grow with you | 17-Sep-2018
| Application Note
3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...
Marken: Global Life Science Supply Chain Solutions | 02-Jul-2018
| Case Study
A desperate mother in Germany urged her team of doctors to reach out to a Marken client on behalf of her two year old girl. The child was battling leukemia...
Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...
Eppendorf for Bioprocess – Solutions that grow with you | 01-May-2018
| Application Note
Viral diseases like rabies, rotavirus and influenza are causing many deaths worldwide, resulting in a strong demand for more productive manufacturing techniques...
Aflibercept (Zaltrap®) is a recombinant fusion protein with complex post-translational modifications. Therefore deep understanding of biosimilar development...
